
Cytarabine - Wikipedia
Cytarabine, also known as cytosine arabinoside (ara-C), is a chemotherapy medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and non-Hodgkin's lymphoma. [2]
Cytarabine, ARA-C injection - Cleveland Clinic
CYTARABINE, ARA-C (sye TARE a been) is a chemotherapy drug. This medicine reduces the growth of cancer cells and can suppress the immune system. It is used for treating leukemias or lymphomas.
Cytarabine (Ara C, cytosine arabinoside) - Cancer Research UK
Cytarabine (Ara C, cytosine arabinoside) Cytarabine is a type of chemotherapy. It is also known as Ara C or cytosine arabinoside. You pronounce cytarabine sye-ta-ra-bin. It is a treatment for: acute leukaemias (cancers of the blood) some lymphomas (cancers of the lymph glands)
Ara-C - Chemocare
CYTARABINE (sye TARE a been) treats leukemia. It works by slowing down the growth of cancer cells. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. What should I tell my care team before I take this medication? This medication is injected into a vein or under the skin.
HiDAC for AML (Acute Myeloid Leukemia) - ChemoExperts
High Dose Ara-C, also known as "HiDAC," is designed to kill the remaining cancer cells after induction chemotherapy is completed. Goals of hidac therapy: HiDAC is commonly given with the goal of cure or to help keep the leukemia in remission until a …
Cytarabine (Ara-C) | HemOnc.org - A Hematology Oncology Wiki
Converted intracellularly into cytarabine-5-triphosphate (ara-CTP). Exact mechanism of action not known; believed to inhibit DNA polymerase, incorporate into DNA and RNA, and kill cells undergoing DNA synthesis (S-phase) and sometimes block cells from progressing from the G1 phase to the S-phase.
Cytarabine Dose for Acute Myeloid Leukemia | New England …
2011年3月17日 · Cytarabine (ara-C) is an important drug in the treatment of acute myeloid leukemia (AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) is toxic but results in...
Ara-C: cellular and molecular pharmacology - PubMed
The antimetabolite cytosine arabinoside (ara-C) represents a prototype of the nucleoside analog class of antineoplastic agents and remains one of the most effective drugs used in the treatment of acute leukemia as well as other hematopoietic malignancies.
Definition of ARA-C - NCI Dictionary of Cancer Terms
A drug used with other drugs to treat adults and children with acute myeloid leukemia and to prevent and treat a type of leukemia that has spread to the meninges (the tissue that covers and protects the brain and spinal cord). It may also be used to treat acute lymphoblastic leukemia and blastic phase chronic myelogenous leukemia.
Cytarabine (Ara C.cytosine arabinoside) - CANCERactive
2018年7月27日 · This patient-friendly article is about chemotherapy drug, Cytarabine (Ara C.cytosine arabinoside) which is mostly used for the treatment of acute myeloid leukaemia (AML), non-Hodgkin’s lymphoma and some head and neck cancers.